Dose-escalation study of SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in postmenopausal women with ER+/HER2- metastatic breast cancer (mBC) Meeting Abstract

  

Authors:	Bardia, A.; Linden, H. M.; Ulaner, G. A.; Chandarlapaty, S.; Gosselin, A.; Doroumian, S.; Celanovic, M.; Campone, M.
Abstract Title:	Dose-escalation study of SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in postmenopausal women with ER+/HER2- metastatic breast cancer (mBC)
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	561s
Language:	English
ACCESSION:	WOS:000487345804051
DOI:	10.1200/JCO.2019.37.15_suppl.1054
PROVIDER:	wos
Notes:	Meeting Abstract: 1054 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156227